OGEN .625 Reviews

Average Rating: 5.0 (2 Ratings)

Filter Results

Compare OGEN .625 with similar:

 Type: Rx Drug

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1

 5  Surgical Menopause at 35 It's been 20+ years so I'm not certain although I've wondered about weight gain I love my Ogen! I've been on it for over 20 years now and hate to think about getting off it. I experienced major depression after my hysterectomy and terrible hot flashes. I was allergic to Premarin and other estrogens. I feel lucky to have found ogen, and think that it has helped my skin remain supple, etc. F 56 20 years
 5  HRT NONE Sticks with you - unlike estrace. Can take it once a day with no hot flashes. When I tried taking estrace I had to take it twice as often at twice the dose and it still didn't work as well as Ogen. I use the generic by Watson FYI. M 40 10 years

OGEN .625  (ESTROPIPATE):  This medication is a female hormone. It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure).   (Sources: U.S. Centers for Medicare Services, FDA)